Medical Marketing and Media

Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Email*

Password*

Keep me logged in Forgot your password?

Email*

2013 Pharma Report: Don't Look Back!

What's that image fading from view? Pharma just sped by one precipice, losing $30 billion in brand revenue to the patent cliff. But another scary patent peak lies ahead. Marc Iskowitz reports

Co-pay/Loyalty Programs: Shuffling the Pack

Co-pay cards and loyalty/CRM programs are a hot topic. As Larry Dobrow finds, a big disconnect still divides the stakeholders in this field

Training & Education: Majoring in Change

When it comes to conveying the changes that have transformed pharma, college degree programs can fall short. The answer may be faculty with pharma marketing experience, writes Joe Dysart

Therapeutic Focus 2013: Rheumatology

Noah Pines on the roll-out of Pfizer's new RA pill Xeljanz, a biologic maker's response, and how the upstart may prompt a move away from needle-based therapies

MM&M Awards 2013: Judging Panel

The 2013 panel features a variety of esteemed leaders, thinkers and experts representing a range of disciplines. Their hard work will determine which agencies win gold on October 2 in New York.

Latest News

Purdue puts Intermezzo DTC to bed

Deborah Weinstein May 16, 2013

Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.

Roche's Rituxan successor receives high marks

Kevin McCaffrey May 16, 2013

Genentech's blockbuster follow-up shows promise in preliminary Phase III data

Pharmas are cool with YouTube but fear Twitter

Matthew Arnold May 15, 2013

Among social media channels, healthcare execs are most comfortable with YouTube and least comfortable with Twitter, a survey suggests.

Tarceva diagnostic brings new indication

Kevin McCaffrey May 15, 2013

Tarceva picks up a first-line indication and a companion diagnostic

Astellas shutters OSI and Perseid, lets 200 US staff go in R&D reorg

May 14, 2013

It was a particularly grim Monday for 200 Astellas employees in the US, who were informed that they were being let go and it was their last day with the company.

Merck's Heller on how to get more women into the C-suite

Marc Iskowitz May 14, 2013

Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.

FDA gut-checks DTC clarity

Deborah Weinstein May 14, 2013

The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer.

J&J's Janssen looks to the margins with hep C agent

Kevin McCaffrey May 14, 2013

J&J scored an unexpected "priority review status" for its HCV agent simeprivir, whose initial approval is expected to be with interferon.

FDA move gives Purdue edge in painkiller market

Deborah Weinstein May 13, 2013

Generic Opana ER got the go-ahead from FDA, exposing the drugmaker to generic competition -- unlike Purdue, whose tamper-proof painkiller won standalone status.

Culture of innovation has a sales value, study says

Marc Iskowitz May 13, 2013

Why executives evaluating biotech acquisitions shouldn't overlook the cultural dimension: A new paper finds a link to revenue performance.

Agency Spotlight

Click here for MM&M’s guide to Healthcare Agencies

Register Now

Latest Issue

The 2013 Pharma Report

While one patent cliff fades into pharma's rear-view, there's another just around the next bend in the road. We take a look at what lies ahead. PLUS: The controversies surrounding co-pay/loyalty programs and the big problem with educating the next generation of marketers

New! 2013 Game Changers

Click here to download the MM&M 2013 Game Changers issue, with a report on trends that are changing the industry and a showcase of companies at the forefront of this transition.

Interactive Guide 2013

The Interactive Guide
Click here to read this special supplement to MM&M, with plenty of trends, data, insights, tips and examples to help you make the most of digital opportunities.

The Mobile Guide

The Mobile Guide 2012
Click here to read up on the latest trends, data, insights and expert advice on the challenges and opportunities of using mobile to reach healthcare professionals and consumers

Latest Features

2013 Pharma Report: Don't Look Back!

Co-pay/Loyalty Programs: Shuffling the Pack

Training & Education: Majoring in Change

Therapeutic Focus 2013: Rheumatology

MM&M Awards 2013: Judging Panel

Headliner: Mike Kaufmann, Cardinal Health

Subscribe to the RSS for this page [view all our RSS feeds here]

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma.